Results 1-7 of 7 (Search time: 0.003 seconds).
Phase III randomized study of postradiotherapy chemotherapy with alpha-difluoromethylornithine-procarbazine, N-(2-chloroethyl)-N'-cyclohexyl-N-nitrosurea, vincristine (DFMO-PCV) versus PCV for glioblastoma multiforme (Journal article)
Phase III randomized study of postradiotherapy chemotherapy with combination alpha-difluoromethylornithine-PCV versus PCV for anaplastic gliomas (Journal article)
The treatment of recurrent unresectable and malignant meningiomas with interferon alpha-2B (Journal article)
Anaplastic oligodendrogliomas: prognostic factors for tumor recurrence and survival (Journal article)
A phase II trial of high-dose bromodeoxyuridine with accelerated fractionation radiotherapy followed by procarbazine, lomustine, and vincristine for glioblastoma multiforme (Journal article)
Mutagen sensitivity and risk of gliomas: a case-control analysis (Journal article)
Prognostic significance of p53 immunoreactivity in patients with glioma (Journal article)